APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Personalized Therapy Biosimulation Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Personalized Therapy Biosimulation Platform Market Outlook and Growth Opportunities 2026

Report ID 174502860412 August 2026197 pages

Choose your research edition.

Industry ResearchPersonalized Therapy Biosimulation Platform Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Personalized Therapy Biosimulation Platform Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Personalized Therapy Biosimulation Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Personalized Therapy Biosimulation Platform Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Personalized Therapy Biosimulation Platform Market Analysis and Forecast 2026-2032177 pages · $4,950 USD

Market perspective

The global Personalized Therapy Biosimulation Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Personalized Therapy Biosimulation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Personalized Therapy Biosimulation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Personalized Therapy Biosimulation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Personalized Therapy Biosimulation Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Personalized Therapy Biosimulation Platform market include Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology, Chemical Computing Group ULC(CCG), Evidera, AnyLogic and Shanghai Lide, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Personalized Therapy Biosimulation Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Personalized Therapy Biosimulation Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Personalized Therapy Biosimulation Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Personalized Therapy Biosimulation Platform market.

Personalized Therapy Biosimulation Platform Segment by Company

Schrodinger

In Silico Biosciences

Genedata

Physiomics

Insilico Biotechology

Chemical Computing Group ULC(CCG)

Evidera

AnyLogic

Shanghai Lide

Cellworks Group

Certara

Simulation Plus

Personalized Therapy Biosimulation Platform Segment by Type

Pharmacokinetic

Pharmacoeconomics

Personalized Therapy Biosimulation Platform Segment by Application

Pharmaceutical and Biotech Companies

Research Institutions

Hospital

Others

Personalized Therapy Biosimulation Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Personalized Therapy Biosimulation Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Personalized Therapy Biosimulation Platform key companies, revenue, market share, and recent developments.

3. To split the Personalized Therapy Biosimulation Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Personalized Therapy Biosimulation Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Personalized Therapy Biosimulation Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Personalized Therapy Biosimulation Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Therapy Biosimulation Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personalized Therapy Biosimulation Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Therapy Biosimulation Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Personalized Therapy Biosimulation Platform industry.

Chapter 3: Detailed analysis of Personalized Therapy Biosimulation Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Personalized Therapy Biosimulation Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Personalized Therapy Biosimulation Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Personalized Therapy Biosimulation Platform Industry Trends Table 2. Personalized Therapy Biosimulation Platform Industry Drivers Table 3. Personalized Therapy Biosimulation Platform Industry Opportunities and Challenges Table 4. Personalized Therapy Biosimulation Platform Industry Restraints Table 5. Global Personalized Therapy Biosimulation Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Personalized Therapy Biosimulation Platform Revenue Share by Company (2021-2026) Table 7. Global Personalized Therapy Biosimulation Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Personalized Therapy Biosimulation Platform Key Company Manufacturing Base & Headquarters Table 9. Global Personalized Therapy Biosimulation Platform Company, Product Type & Application Table 10. Global Personalized Therapy Biosimulation Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Personalized Therapy Biosimulation Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pharmacokinetic Table 15. Significant Companies of Pharmacoeconomics Table 16. Global Personalized Therapy Biosimulation Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Personalized Therapy Biosimulation Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Personalized Therapy Biosimulation Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Personalized Therapy Biosimulation Platform Sales Value Share by Type (2021-2026) Table 20. Global Personalized Therapy Biosimulation Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical and Biotech Companies Table 22. Significant Companies of Research Institutions Table 23. Significant Companies of Hospital Table 24. Significant Companies of Others Table 25. Global Personalized Therapy Biosimulation Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Personalized Therapy Biosimulation Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Personalized Therapy Biosimulation Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Personalized Therapy Biosimulation Platform Sales Value Share by Application (2021-2026) Table 29. Global Personalized Therapy Biosimulation Platform Sales Value Share by Application (2027-2032) Table 30. Global Personalized Therapy Biosimulation Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Personalized Therapy Biosimulation Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Personalized Therapy Biosimulation Platform Sales Value Share by Region (2021-2026) Table 33. Global Personalized Therapy Biosimulation Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Personalized Therapy Biosimulation Platform Sales Value Share by Region (2027-2032) Table 35. Global Personalized Therapy Biosimulation Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Personalized Therapy Biosimulation Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Personalized Therapy Biosimulation Platform Sales Value Market Share by Country (2021-2026) Table 38. Global Personalized Therapy Biosimulation Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Personalized Therapy Biosimulation Platform Sales Value Market Share by Country (2027-2032) Table 40. Schrodinger Company Information Table 41. Schrodinger Business Overview Table 42. Schrodinger Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Schrodinger Personalized Therapy Biosimulation Platform Product Portfolio Table 44. Schrodinger Recent Development Table 45. In Silico Biosciences Company Information Table 46. In Silico Biosciences Business Overview Table 47. In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. In Silico Biosciences Personalized Therapy Biosimulation Platform Product Portfolio Table 49. In Silico Biosciences Recent Development Table 50. Genedata Company Information Table 51. Genedata Business Overview Table 52. Genedata Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Genedata Personalized Therapy Biosimulation Platform Product Portfolio Table 54. Genedata Recent Development Table 55. Physiomics Company Information Table 56. Physiomics Business Overview Table 57. Physiomics Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Physiomics Personalized Therapy Biosimulation Platform Product Portfolio Table 59. Physiomics Recent Development Table 60. Insilico Biotechology Company Information Table 61. Insilico Biotechology Business Overview Table 62. Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Insilico Biotechology Personalized Therapy Biosimulation Platform Product Portfolio Table 64. Insilico Biotechology Recent Development Table 65. Chemical Computing Group ULC(CCG) Company Information Table 66. Chemical Computing Group ULC(CCG) Business Overview Table 67. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product Portfolio Table 69. Chemical Computing Group ULC(CCG) Recent Development Table 70. Evidera Company Information Table 71. Evidera Business Overview Table 72. Evidera Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Evidera Personalized Therapy Biosimulation Platform Product Portfolio Table 74. Evidera Recent Development Table 75. AnyLogic Company Information Table 76. AnyLogic Business Overview Table 77. AnyLogic Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. AnyLogic Personalized Therapy Biosimulation Platform Product Portfolio Table 79. AnyLogic Recent Development Table 80. Shanghai Lide Company Information Table 81. Shanghai Lide Business Overview Table 82. Shanghai Lide Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Shanghai Lide Personalized Therapy Biosimulation Platform Product Portfolio Table 84. Shanghai Lide Recent Development Table 85. Cellworks Group Company Information Table 86. Cellworks Group Business Overview Table 87. Cellworks Group Personalized Therapy Biosimulation Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Cellworks Group Personalized Therapy Biosimulation Platform Product Portfolio Table 89. Cellworks Group Recent Development Table 90. Certara Company Information Table 91. Certara Business Overview Table 92. Certara Personalized Therapy Biosimulation Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Certara Personalized Therapy Biosimulation Platform Product Portfolio Table 94. Certara Recent Development Table 95. Simulation Plus Company Information Table 96. Simulation Plus Business Overview Table 97. Simulation Plus Personalized Therapy Biosimulation Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Simulation Plus Personalized Therapy Biosimulation Platform Product Portfolio Table 99. Simulation Plus Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Personalized Therapy Biosimulation Platform Product Image Figure 2. Global Personalized Therapy Biosimulation Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Personalized Therapy Biosimulation Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Personalized Therapy Biosimulation Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pharmacokinetic Image Figure 8. Pharmacoeconomics Image Figure 9. Global Personalized Therapy Biosimulation Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Personalized Therapy Biosimulation Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Personalized Therapy Biosimulation Platform Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical and Biotech Companies Image Figure 13. Research Institutions Image Figure 14. Hospital Image Figure 15. Others Image Figure 16. Global Personalized Therapy Biosimulation Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Personalized Therapy Biosimulation Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Personalized Therapy Biosimulation Platform Sales Value Share by Application (2021-2032) Figure 19. Global Personalized Therapy Biosimulation Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Personalized Therapy Biosimulation Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Personalized Therapy Biosimulation Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Personalized Therapy Biosimulation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Personalized Therapy Biosimulation Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Personalized Therapy Biosimulation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Personalized Therapy Biosimulation Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Personalized Therapy Biosimulation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Personalized Therapy Biosimulation Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Personalized Therapy Biosimulation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Personalized Therapy Biosimulation Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Personalized Therapy Biosimulation Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmacokinetic
  • Pharmacoeconomics
Applications
  • Pharmaceutical and Biotech Companies
  • Research Institutions
  • Hospital
  • Others
Companies covered
  • Schrodinger
  • In Silico Biosciences
  • Genedata
  • Physiomics
  • Insilico Biotechology
  • Chemical Computing Group ULC(CCG)
  • Evidera
  • AnyLogic
  • Shanghai Lide
  • Cellworks Group
  • Certara
  • Simulation Plus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Personalized Therapy Biosimulation Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Personalized Therapy Biosimulation Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Personalized Therapy Biosimulation Platform Market Dynamics
  1. 2.1 Personalized Therapy Biosimulation Platform Industry Trends
  2. 2.2 Personalized Therapy Biosimulation Platform Industry Drivers
  3. 2.3 Personalized Therapy Biosimulation Platform Industry Opportunities and Challenges
  4. 2.4 Personalized Therapy Biosimulation Platform Industry Restraints
3 Personalized Therapy Biosimulation Platform Market by Company
  1. 3.1 Global Personalized Therapy Biosimulation Platform Company Revenue Ranking in 2025
  2. 3.2 Global Personalized Therapy Biosimulation Platform Revenue by Company (2021-2026)
  3. 3.3 Global Personalized Therapy Biosimulation Platform Company Ranking (2024-2026)
  4. 3.4 Global Personalized Therapy Biosimulation Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Personalized Therapy Biosimulation Platform Company Product Type and Application
  6. 3.6 Global Personalized Therapy Biosimulation Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Personalized Therapy Biosimulation Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Personalized Therapy Biosimulation Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Personalized Therapy Biosimulation Platform Market by Type
  1. 4.1 Personalized Therapy Biosimulation Platform Type Introduction
  2. 4.1.1 Pharmacokinetic
  3. 4.1.2 Pharmacoeconomics
  4. 4.2 Global Personalized Therapy Biosimulation Platform Sales Value by Type
  5. 4.2.1 Global Personalized Therapy Biosimulation Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Personalized Therapy Biosimulation Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Personalized Therapy Biosimulation Platform Sales Value Share by Type (2021-2032)
5 Personalized Therapy Biosimulation Platform Market by Application
  1. 5.1 Personalized Therapy Biosimulation Platform Application Introduction
  2. 5.1.1 Pharmaceutical and Biotech Companies
  3. 5.1.2 Research Institutions
  4. 5.1.3 Hospital
  5. 5.1.4 Others
  6. 5.2 Global Personalized Therapy Biosimulation Platform Sales Value by Application
  7. 5.2.1 Global Personalized Therapy Biosimulation Platform Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Personalized Therapy Biosimulation Platform Sales Value by Application (2021-2032)
  9. 5.2.3 Global Personalized Therapy Biosimulation Platform Sales Value Share by Application (2021-2032)
6 Personalized Therapy Biosimulation Platform Regional Value Analysis
  1. 6.1 Global Personalized Therapy Biosimulation Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Personalized Therapy Biosimulation Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Personalized Therapy Biosimulation Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Personalized Therapy Biosimulation Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Personalized Therapy Biosimulation Platform Sales Value (2021-2032)
  7. 6.3.2 North America Personalized Therapy Biosimulation Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Personalized Therapy Biosimulation Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Personalized Therapy Biosimulation Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Personalized Therapy Biosimulation Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Personalized Therapy Biosimulation Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Personalized Therapy Biosimulation Platform Sales Value (2021-2032)
  16. 6.6.2 South America Personalized Therapy Biosimulation Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Personalized Therapy Biosimulation Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Personalized Therapy Biosimulation Platform Sales Value Share by Country, 2025 VS 2032
7 Personalized Therapy Biosimulation Platform Country-level Value Analysis
  1. 7.1 Global Personalized Therapy Biosimulation Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Personalized Therapy Biosimulation Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Personalized Therapy Biosimulation Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Personalized Therapy Biosimulation Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Personalized Therapy Biosimulation Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Personalized Therapy Biosimulation Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Personalized Therapy Biosimulation Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Schrodinger
  2. 8.1.1 Schrodinger Company Information
  3. 8.1.2 Schrodinger Business Overview
  4. 8.1.3 Schrodinger Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Schrodinger Personalized Therapy Biosimulation Platform Product Portfolio
  6. 8.1.5 Schrodinger Recent Developments
  7. 8.2 In Silico Biosciences
  8. 8.2.1 In Silico Biosciences Company Information
  9. 8.2.2 In Silico Biosciences Business Overview
  10. 8.2.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 In Silico Biosciences Personalized Therapy Biosimulation Platform Product Portfolio
  12. 8.2.5 In Silico Biosciences Recent Developments
  13. 8.3 Genedata
  14. 8.3.1 Genedata Company Information
  15. 8.3.2 Genedata Business Overview
  16. 8.3.3 Genedata Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genedata Personalized Therapy Biosimulation Platform Product Portfolio
  18. 8.3.5 Genedata Recent Developments
  19. 8.4 Physiomics
  20. 8.4.1 Physiomics Company Information
  21. 8.4.2 Physiomics Business Overview
  22. 8.4.3 Physiomics Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Physiomics Personalized Therapy Biosimulation Platform Product Portfolio
  24. 8.4.5 Physiomics Recent Developments
  25. 8.5 Insilico Biotechology
  26. 8.5.1 Insilico Biotechology Company Information
  27. 8.5.2 Insilico Biotechology Business Overview
  28. 8.5.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Insilico Biotechology Personalized Therapy Biosimulation Platform Product Portfolio
  30. 8.5.5 Insilico Biotechology Recent Developments
  31. 8.6 Chemical Computing Group ULC(CCG)
  32. 8.6.1 Chemical Computing Group ULC(CCG) Company Information
  33. 8.6.2 Chemical Computing Group ULC(CCG) Business Overview
  34. 8.6.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product Portfolio
  36. 8.6.5 Chemical Computing Group ULC(CCG) Recent Developments
  37. 8.7 Evidera
  38. 8.7.1 Evidera Company Information
  39. 8.7.2 Evidera Business Overview
  40. 8.7.3 Evidera Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Evidera Personalized Therapy Biosimulation Platform Product Portfolio
  42. 8.7.5 Evidera Recent Developments
  43. 8.8 AnyLogic
  44. 8.8.1 AnyLogic Company Information
  45. 8.8.2 AnyLogic Business Overview
  46. 8.8.3 AnyLogic Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AnyLogic Personalized Therapy Biosimulation Platform Product Portfolio
  48. 8.8.5 AnyLogic Recent Developments
  49. 8.9 Shanghai Lide
  50. 8.9.1 Shanghai Lide Company Information
  51. 8.9.2 Shanghai Lide Business Overview
  52. 8.9.3 Shanghai Lide Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shanghai Lide Personalized Therapy Biosimulation Platform Product Portfolio
  54. 8.9.5 Shanghai Lide Recent Developments
  55. 8.10 Cellworks Group
  56. 8.10.1 Cellworks Group Company Information
  57. 8.10.2 Cellworks Group Business Overview
  58. 8.10.3 Cellworks Group Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cellworks Group Personalized Therapy Biosimulation Platform Product Portfolio
  60. 8.10.5 Cellworks Group Recent Developments
  61. 8.11 Certara
  62. 8.11.1 Certara Company Information
  63. 8.11.2 Certara Business Overview
  64. 8.11.3 Certara Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Certara Personalized Therapy Biosimulation Platform Product Portfolio
  66. 8.11.5 Certara Recent Developments
  67. 8.12 Simulation Plus
  68. 8.12.1 Simulation Plus Company Information
  69. 8.12.2 Simulation Plus Business Overview
  70. 8.12.3 Simulation Plus Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Simulation Plus Personalized Therapy Biosimulation Platform Product Portfolio
  72. 8.12.5 Simulation Plus Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst